• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 13 Apr

    Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe

    Novel hemostatic wound dressing provides distinctive features FRAMINGHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced receipt of the CE (Conformité Européenne) mark for its first-in-class wound care… Read More..

    Share this:
  • 25 Jun

    PCG Advisory Launches New Corporate Website at PCGAdvisory.com

    New Website Offers More Comprehensive Understanding of PCG’s Value Proposition and Overall Client Benefits New York City, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- PCG Advisory, Inc., a leading investor relations, strategic communications and cutting-edge digital marketing firm, today announced the launch of its new redesigned website,… Read More..

    Share this:
  • 19 Jun

    PCG Advisory CEO Jeff Ramson to Participate on “Insights on Investor Relations: Utilizing Digital Channels for Digital Securities to Maintain Trust, Engagement, & Compliance” Webinar Hosted by KoreConX

    Webinar taking place on Wednesday, June 19th at 11:00 AM EDT NEW YORK, NY, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- PCG Advisory Inc., a leading New York City-based investor relations and digital strategies firm, today announced that Jeff Ramson, Founder and CEO, will participate on a webinar panel… Read More..

    Share this:
« Previous 1 … 219 220 221 222 223 … 233 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact